These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30896263)

  • 1. Immunostaining characteristics of irisin in benign and malignant renal cancers.
    Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S
    Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A promising biomarker to distinguish benign and malignant renal tumors: ELABELA.
    Artas G; Kuloglu T; Dagli AF; Ugur K; Yardim M; Aydin S; Artas H; Kocdor H
    Niger J Clin Pract; 2019 Mar; 22(3):386-392. PubMed ID: 30837428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.
    Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ
    Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules.
    Iakymenko OA; Delma KS; Jorda M; Kryvenko ON
    Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165
    [No Abstract]   [Full Text] [Related]  

  • 7. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
    Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
    Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
    Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
    Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
    Brunelli M; Erdini F; Cima L; Eccher A; Fioravanzo A; Gobbo S; Segala D; Ghimenton C; Mazzoleni G; Munari E; Carella R; Martignoni G
    Appl Immunohistochem Mol Morphol; 2018; 26(5):316-323. PubMed ID: 27556823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.
    McHugh JB; Hoschar AP; Dvorakova M; Parwani AV; Barnes EL; Seethala RR
    Head Neck Pathol; 2007 Dec; 1(2):123-31. PubMed ID: 20614263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
    Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
    Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.
    Gaut JP; Crimmins DL; Lockwood CM; McQuillan JJ; Ladenson JH
    Mod Pathol; 2013 May; 26(5):716-24. PubMed ID: 23196795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY; Mills SE
    Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review.
    McCroskey Z; Sim SJ; Selzman AA; Ayala AG; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():32-36. PubMed ID: 28807339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.